If you or someone you love has suffered from bleeding, hemorrhaging or death from taking Xarelto (rivaroxaban), then you may be eligible for compensation through a Xarelto lawsuit. Contact a the office of Griffin & Bivalacqua for a consultation. Our personal injury lawyers represent Xarelto victims throughout Louisiana and across the Gulf Coast.
Xarelto is manufactured by Bayer and marketed by Johnson & Johnson’s subsidiary, Janssen Pharmaceuticals. Xarelto is one of the newer blood thinners on the market. There have been a lot of concerns about Xarelto’s safety.
Xarelto was approved by the U.S. Food & Drug Administration (FDA) in July 2011 for the prevention of a type of blood clot known as deep vein thrombosis (DVT), a condition that commonly occurs after certain types of surgeries.
The drug is also commonly prescribed to reduce the risk of stroke in patients with a certain type of heart rhythm disorder.
The most dangerous side effect for people taking Xarelto is uncontrollable bleeding – a risk shared by all blood thinners.
Risks and side effects for blood thinners like Xarelto include:
While internal bleeding is a risk of any blood thinner, other drugs have emergency antidotes to reverse the effects if internal bleeding develops. There is no antidote for Xarelto, so if a patient on the drug experiences internal bleeding, doctors must find other ways to combat the problem while the drug is flushed from the patient’s system.
* Both the FDA and the makers of Xarelto advise against making any changes in your medication without consulting with your doctor.
If you or a loved one think Xarelto caused you or a loved one uncontrolled bleeding or another serious complication then contact our drug litigation lawyers at Griffin and Bivalacqua in New Orleans, Louisiana to see if you qualify for a Xarelto lawsuit.
Most cases involving pharmaceuticals allege that a drug was sold with design, manufacturing, and/or marketing defects, which typically refers to a company’s failure to warn of a certain side effect.
In the case of Xarelto, our attorneys suspect that patients may be able to take legal action in light of claims that Janssen failed to adequately warn doctors and patients about the risk of uncontrollable internal bleeding events.
Call us at (504) 648-1858. We are dedicated to ensuring that individuals receive the highest-quality legal representation available.
Contact Us